Rabbit Polyclonal JNK1 antibody. Suitable for IHC-P, WB and reacts with Rat, Human, Mouse samples. Cited in 43 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK8.
View Alternative Names
JNK1, PRKM8, SAPK1, SAPK1C, MAPK8, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, JNK-46, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, SAPK1c
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JNK1 + JNK2 antibody (AB112501)
ab112501 staining JNK1+JNK2 in Human intestinal cancer tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JNK1 + JNK2 antibody (AB112501)
ab112501 staining JNK1+JNK2 in Rat intestinal tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
- WB
Unknown
Western blot - Anti-JNK1 + JNK2 antibody (AB112501)
All lanes:
Western blot - Anti-JNK1 + JNK2 antibody (ab112501)
Lane 1:
Rat brain tissue lysate
Lane 2:
Rat thymus tissue lysate
Lane 3:
MCF-7 whole cell lysate
Lane 4:
HeLa whole cell lysate
Lane 5:
Jurkat whole cell lysate
Lane 6:
MM231 whole cell lysate
Lane 7:
6T-CEM whole cell lysate
Predicted band size: 48 kDa
Observed band size: 55 kDa
false
- WB
CiteAb
Western blot - Anti-JNK1 + JNK2 antibody (AB112501)
JNK1 + JNK2 western blot using anti-JNK1 + JNK2 antibody ab112501. Publication image and figure legend from Yang, C., Yan, Z., et al., 2020, Cancer Cell Int, PubMed 32015692.
ab112501 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab112501 please see the product overview.
miR-517a inhibition suppressed activation of the JNK signaling pathway by targeting CDKN1C. a Binding of miR-517a to CDKN1C confirmed by dual-luciferase reporter assay; *p < 0.05 compared with cells treated with empty vector. b miR-517a expression and mRNA level of CDKN1C in cells detected using RT-qPCR. c, d Western blot analysis of CDKN1C, JNK, and p38 proteins in cells. *p < 0.05 compared with cells without treatment; #p < 0.05 compared with cells treated with NC inhibitor; &p < 0.05, compared with the cells treated with pcDNA-NC. All data were expressed as mean ± standard deviation; comparisons among multiple groups were analyzed by one-way ANOVA; the experiment was repeated three times
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These enzymes play vital roles in regulating cellular responses to stress stimuli. JNK1 and JNK2 form part of larger signaling complexes including the JNK molecular weight complex that is activated in stressful conditions like UV radiation or cytokines. Once activated they phosphorylate transcription factors such as c-Jun leading to gene expression changes that facilitate adaptative and survival responses. They modulate cellular processes like apoptosis inflammation and cell differentiation clearly contributing to homeostasis and development.
Pathways
These kinases interact significantly within the MAPK (Mitogen-activated protein kinase) and apoptosis pathways. JNK proteins mediate signals from upstream kinases such as MKK4/7 and respond to inflammatory cytokines resulting in transcriptional alterations. Their downstream impact is tightly linked to apoptosis through interactions with Bcl-2 family members affecting cellular fate. ERK and p38 MAPK proteins closely interact with JNK pathways co-regulating cellular stress responses and survival pathways highlighting their importance in maintaining cellular balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (43)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 53: PubMed38214344
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental biology and medicine (Maywood, N.J.) 248:2421-2439 PubMed38059322
2023
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2023:2453402 PubMed36865085
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 17:1780-1787 PubMed36447525
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 22:478 PubMed36352396
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 14:940166 PubMed36051307
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:1612829 PubMed35990822
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:13882-13892 PubMed35707829
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bosnian journal of basic medical sciences 22:217-228 PubMed34813418
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1365 PubMed34659511
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com